BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14734617)

  • 1. Immunologic immaturity, but high IL-4 productivity, of murine neonatal thymic CD4 single-positive T cells in the last stage of maturation.
    Koyanagi M; Imanishi K; Arimura Y; Kato H; Yagi J; Uchiyama T
    Int Immunol; 2004 Feb; 16(2):315-26. PubMed ID: 14734617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-thymic maturation of migrating human thymic single-positive T cells: thymic CD1a- CD4+ T cells are more susceptible to anergy induction by toxic shock syndrome toxin-1 than cord blood CD4+ T cells.
    Imanishi K; Seo K; Kato H; Miyoshi-Akiyama T; Zhang RH; Takanashi Y; Imai Y; Uchiyama T
    J Immunol; 1998 Jan; 160(1):112-9. PubMed ID: 9551963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory roles of IL-2 and IL-4 in H4/inducible costimulator expression on activated CD4+ T cells during Th cell development.
    Yagi J; Arimura Y; Dianzani U; Uede T; Okamoto T; Uchiyama T
    J Immunol; 2003 Jul; 171(2):783-94. PubMed ID: 12847246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional uncoupling of T-cell receptor engagement and Lck activation in anergic human thymic CD4+ T cells.
    Fujimaki W; Iwashima M; Yagi J; Zhang H; Yagi H; Seo K; Imai Y; Imanishi K; Uchiyama T
    J Biol Chem; 2001 May; 276(20):17455-60. PubMed ID: 11279170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enforced expression of GATA-3 during T cell development inhibits maturation of CD8 single-positive cells and induces thymic lymphoma in transgenic mice.
    Nawijn MC; Ferreira R; Dingjan GM; Kahre O; Drabek D; Karis A; Grosveld F; Hendriks RW
    J Immunol; 2001 Jul; 167(2):715-23. PubMed ID: 11441075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of high level IL-2 production in CD4+8- T helper lymphocytes requires post-thymic development.
    Chang JF; Thomas CA; Kung JT
    J Immunol; 1991 Aug; 147(3):851-9. PubMed ID: 1677670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of murine thymic epithelial cell line (MTEC1) on the functional expression of CD4(+)CD8(-) thymocyte subgroups.
    Ge Q; Chen WF
    Int Immunol; 2000 Aug; 12(8):1127-33. PubMed ID: 10917887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T(h)1/T(h)2 cell differentiation of developing CD4 single-positive thymocytes.
    Kikkawa E; Yamashita M; Kimura M; Omori M; Sugaya K; Shimizu C; Katsumoto T; Ikekita M; Taniguchi M; Nakayama T
    Int Immunol; 2002 Aug; 14(8):943-51. PubMed ID: 12147631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation events during thymic selection.
    Bendelac A; Matzinger P; Seder RA; Paul WE; Schwartz RH
    J Exp Med; 1992 Mar; 175(3):731-42. PubMed ID: 1740662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
    Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
    Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment.
    Yamane H; Zhu J; Paul WE
    J Exp Med; 2005 Sep; 202(6):793-804. PubMed ID: 16172258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenic dendritic cells pulsed with Ixodes ricinus tick saliva prime naive CD4+T to induce Th2 cell differentiation in vitro and in vivo.
    Mejri N; Brossard M
    Int Immunol; 2007 Apr; 19(4):535-43. PubMed ID: 17344202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of thymic CD4+CD25+ regulatory T cells and their co-stimulatory requirements are determined after elimination of recirculating peripheral CD4+ cells.
    Zhan Y; Bourges D; Dromey JA; Harrison LC; Lew AM
    Int Immunol; 2007 Apr; 19(4):455-63. PubMed ID: 17314081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo.
    Röcken M; Urban J; Shevach EM
    J Exp Med; 1994 Jun; 179(6):1885-93. PubMed ID: 7910842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation and cytokine production by CD4+ cells from old mice.
    Hobbs MV; Ernst DN; Torbett BE; Glasebrook AL; Rehse MA; McQuitty DN; Thoman ML; Bottomly K; Rothermel AL; Noonan DJ
    J Cell Biochem; 1991 Aug; 46(4):312-20. PubMed ID: 1684583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells.
    Pai SY; Truitt ML; Ho IC
    Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1993-8. PubMed ID: 14769923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helper interleukins are produced by both CD4 and CD8 splenic T cells after mitogen stimulation.
    Cardell S; Sander B; Möller G
    Eur J Immunol; 1991 Oct; 21(10):2495-500. PubMed ID: 1680700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential partitioning and trafficking of GM gangliosides and cholesterol-rich lipid rafts in thymic and splenic CD4 T cells.
    Brumeanu TD; Preda-Pais A; Stoica C; Bona C; Casares S
    Mol Immunol; 2007 Jan; 44(4):530-40. PubMed ID: 16597465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
    Suda T; Murray R; Guidos C; Zlotnik A
    J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.